Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

Atlas Reaction Calorimetry System

Product Description

atlas_calorimeter_system copy.gif

The Atlas Calorimeter is high performance, low cost and easy to use. Using either Heat Flow Calorimetry (HFC) or Power Compensation Calorimetry (PCC), Atlas can generate power and enthalpy graphs at the click of a button.

The Calorimeter is part of Atlas from Syrris, a revolutionary range of modular products, which can form a wide range of lab reactors - designed specifically for research and development chemists. Atlas offers manual or automated control of one or many reactions at a time with volumes from 5 litres to 1ml in jacketed reactors, flasks or vials.

Features & Benefits

Fully automated: Temperature control, set up and operation are all automated.

Excellent control: Sophisticated PID control and powerful circulators result in accurate isothermal performance.

Accurate: Vacuum jacketed vessels, automated calibration and sensitive RTDs give extremely high accuracy results.

Walk away operation: Automated gravimetric or volumetric reagents additions are all made easy.

High performance overhead stirrer: Improved formulation consistency, stability and performance of final drug products.

Easy analysis: Easy to use software allows graphs of power and enthalpy to be plotted with one click.

Quick: Everything clicks together quickly and easily without the need for tools. Vessels can be changed in under 1 minute.

Flexible: The same equipment and software can be used for HFC or PCC, allowing the chemist to pick the best method for the reaction.

Product Atlas Reaction Calorimetry System
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos